Filling the need for trusted information on national health issues…

Private Sector Involvement

  • Your Selections:

Refine Results

date

Tags

Pharmaceutical Companies Signal Reluctance To Continue Status Quo In Disease Outbreak Responses

STAT: An ‘unsustainable’ model: Drug makers signal interest in exiting vaccine development during crises “Every few years an alarming disease launches a furious, out-of-the-blue attack on people, triggering a high-level emergency response. … In nearly each case, major vaccine producers have risen to the challenge, setting aside their day-to-day profit-making…

HHS Secretary Nominee Alex Azar’s History With Pharmaceutical Industry Could Threaten Access To Medicines, U.S. Global Health Initiatives

The Hill: Alex Azar is bad medicine for HHS Hilary McQuie, director of U.S. policy and grassroots mobilization at the Health Global Access Project (GAP) “…Americans want government action to address the crisis of out of control domestic drug price increases, and they overwhelmingly support successful global health initiatives overseas…

Public-Private Partnerships Critical To Ensuring Adequate Global Health Financing

Devex: Opinion: How public-private partnerships can unlock billions for health financing Arnaud Bernaert, head of global health and healthcare industries and system initiative at the World Economic Forum, and Dessislava Dimitrova, lead for health systems and healthcare joint ventures at the World Economic Forum “…Recent estimates by the World Health…

WHO Committee Recommends Limited Use Of Sanofi’s Dengue Vaccine

STAT: Experts call for use of Sanofi’s dengue vaccine to be halted in most cases “The use of the world’s first dengue vaccine should be temporarily suspended except in limited circumstances because of concerns that it could put some people at heightened risk of severe disease, according to prominent public…

Brookings Institution Analysis Examines Profitability Of New Drug Development For Neglected Diseases

Brookings Institution’s “TechTank”: Are drugs for neglected diseases profitable? Jake Schneider, research assistant, and Jeremy Barofsky, non-resident fellow in governance studies, both with Brookings, discuss their new analysis in which they examine the profitability of new drugs for neglected diseases “using various incentive mechanisms.” They write, “Ultimately, we recommend necessary…

Public-Private Partnerships Vital To Making Progress Against NTDs

Devex: Opinion: How public-private partnerships are combating NTDs Matshidiso Rebecca Moeti, WHO regional director for Africa “…Thanks to an innovative public-private partnership, we’ve seen remarkable progress against [neglected tropical diseases (NTDs)]. In an unprecedented move, 13 of the largest pharmaceutical companies have pulled together under the auspices of the CEO…

NTD Progress Report Shows Numbers Of People Affected By Diseases Down, 1B People Received Treatment, Challenges Remain

Los Angeles Times: Guinea worm, river blindness and elephantiasis are among the world’s neglected tropical diseases. A battle is on to wipe them out “…[T]he combined efforts of governments, nonprofit organizations, academia, and the private sector have helped combat neglected tropical diseases, or NTDs, during the last five years, according…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.